Free Trial
NASDAQ:FENC

Adherex Technologies (FENC) Stock Price, News & Analysis

Adherex Technologies logo
$9.04 +0.15 (+1.69%)
Closing price 04:00 PM Eastern
Extended Trading
$9.05 +0.01 (+0.11%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Adherex Technologies Stock (NASDAQ:FENC)

Key Stats

Today's Range
$8.70
$9.11
50-Day Range
$5.97
$8.89
52-Week Range
$3.96
$9.12
Volume
123,640 shs
Average Volume
92,550 shs
Market Capitalization
$249.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00
Consensus Rating
Buy

Company Overview

Adherex Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

FENC MarketRank™: 

Adherex Technologies scored higher than 46% of companies evaluated by MarketBeat, and ranked 594th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Adherex Technologies has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Adherex Technologies has only been the subject of 2 research reports in the past 90 days.

  • Read more about Adherex Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for Adherex Technologies are expected to decrease in the coming year, from ($0.11) to ($0.15) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Adherex Technologies is -17.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Adherex Technologies is -17.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Adherex Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    5.91% of the float of Adherex Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Adherex Technologies has a short interest ratio ("days to cover") of 16.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Adherex Technologies has recently decreased by 4.23%, indicating that investor sentiment is improving.
  • Dividend Yield

    Adherex Technologies does not currently pay a dividend.

  • Dividend Growth

    Adherex Technologies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.91% of the float of Adherex Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Adherex Technologies has a short interest ratio ("days to cover") of 16.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Adherex Technologies has recently decreased by 4.23%, indicating that investor sentiment is improving.
  • News Sentiment

    Adherex Technologies has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Adherex Technologies this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Adherex Technologies insiders have sold 126.33% more of their company's stock than they have bought. Specifically, they have bought $104,602.00 in company stock and sold $236,746.00 in company stock.

  • Percentage Held by Insiders

    11.76% of the stock of Adherex Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    55.51% of the stock of Adherex Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Adherex Technologies' insider trading history.
Receive FENC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adherex Technologies and its competitors with MarketBeat's FREE daily newsletter.

FENC Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Fennec Announces Results of Annual Meeting
Fennec - A Sound Case For Long-Term Growth?
See More Headlines

FENC Stock Analysis - Frequently Asked Questions

Adherex Technologies' stock was trading at $6.32 at the start of the year. Since then, FENC shares have increased by 43.0% and is now trading at $9.04.

Adherex Technologies Inc. (NASDAQ:FENC) announced its earnings results on Tuesday, May, 13th. The company reported ($0.04) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.08. The business had revenue of $8.51 million for the quarter, compared to analysts' expectations of $8.18 million.
Read the conference call transcript
.

Shares of FENC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Adherex Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Alphabet (GOOG).

Company Calendar

Last Earnings
5/13/2025
Today
7/10/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:FENC
CIK
1211583
Employees
10
Year Founded
N/A

Price Target and Rating

High Price Target
$13.00
Low Price Target
$13.00
Potential Upside/Downside
+48.4%
Consensus Rating
Buy
Rating Score (0-4)
3.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$440 thousand
Net Margins
-45.52%
Pretax Margin
-45.53%
Return on Equity
N/A
Return on Assets
-26.37%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.13
Quick Ratio
4.97

Sales & Book Value

Annual Sales
$47.54 million
Price / Sales
5.09
Cash Flow
$0.03 per share
Price / Cash Flow
269.39
Book Value
($0.21) per share
Price / Book
-41.71

Miscellaneous

Outstanding Shares
27,600,000
Free Float
24,354,000
Market Cap
$241.78 million
Optionable
Optionable
Beta
0.39
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:FENC) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners